The real-world efficacy and safety of anamorelin hydrochloride for Japanese unresectable non-small cell lung cancer patients with cachexia

被引：0
|
作者：
Arai, D. [1 ]
Kido, R. [1 ]
Yamaguchi, J. [1 ]
Kamimoto, S. [1 ]
Furuya, S. [1 ]
Kanzawa, A. [1 ]
Miyazaki, M. [1 ]
Baba, R. [1 ]
Okamori, S. [1 ]
Takahashi, H. [1 ]
Nakachi, I. [1 ]
机构：
[1] Saiseikai Utsunomiya Hosp, Dept Internal Med, Pulm Div, Utsunomiya, Tochigi, Japan
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.10.537
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
451P
引用
收藏
页码：S1638 / S1639
页数：2
相关论文
共 50 条
  • [1] Predictors of efficacy of anamorelin in patients with non-small cell lung cancer and cachexia: A retrospective study
    Ishioka, Yoshiko
    Tanaka, Hisashi
    Makiguchi, Tomonori
    Fujishima, Syunsuke
    Nunomura, Yasuhito
    Sakamoto, Hiroaki
    Shiratori, Toshihiro
    Taima, Kageaki
    Tasaka, Sadatomo
    [J]. ONCOLOGY LETTERS, 2024, 27 (01)
  • [2] The real-world efficacy and safety of anlotinib in advanced non-small cell lung cancer
    Fen Wang
    Feng Jin
    Boran Cheng
    Yue Zhang
    Qing Zhou
    Shubin Wang
    [J]. Journal of Cancer Research and Clinical Oncology, 2022, 148 : 1721 - 1735
  • [3] The real-world efficacy and safety of anlotinib in advanced non-small cell lung cancer
    Wang, Fen
    Jin, Feng
    Cheng, Boran
    Zhang, Yue
    Zhou, Qing
    Wang, Shubin
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (07) : 1721 - 1735
  • [4] Efficacy and Safety of Anlotinib in Patients with Advanced Non-Small Cell Lung Cancer: A Real-World Study
    Zhong, Qiuxia
    Liu, Zhihua
    [J]. CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 4115 - 4128
  • [5] Safety of pembrolizumab in patients with non-small cell lung cancer: a real-world study
    Thakrar, D. B.
    Essang, B.
    Echlin, A.
    Murdock, C.
    Lind, M. J.
    [J]. LUNG CANCER, 2019, 127 : S40 - S41
  • [6] The Real-World Efficacy and Safety of Anlotinib Treatment for Advanced Non-Small Cell Lung Cancer
    Wang, F.
    Jin, F.
    Wang, S.
    Zhu, Y.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S673 - S673
  • [7] Efficacy and Safety of Anlotinib in Advanced Non-Small Cell Lung Cancer: A Real-World Study
    Zhang, Kun
    Ma, Xiya
    Gao, Hongjun
    Wang, Hong
    Qin, Haifeng
    Yang, Shaoxing
    Liu, Xiaoqing
    [J]. CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 3409 - 3417
  • [8] A Real-World Study: Efficacy and Safety of Anlotinib for Advanced Non-Small Cell Lung Cancer
    Wang, J.
    Yi, T.
    Dong, Y.
    Ran, R.
    Cao, F.
    Li, Y.
    Luo, Z.
    Xu, Y.
    Fu, Y.
    Kuang, L.
    Chen, G.
    Qu, G.
    Yin, Y.
    Li, J.
    Xu, X.
    Chen, Y.
    Song, Q.
    Chu, Q.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1071 - S1071
  • [9] Real-world efficacy and safety of pembrolizumab in patients with non-small cell lung cancer: a retrospective observational study
    Cavaille, Francois
    Peretti, Mathieu
    Garcia, Marie Eve
    Giorgi, Roch
    Ausias, Nathalie
    Vanelle, Patrice
    Barlesi, Fabrice
    Montana, Marc
    [J]. TUMORI JOURNAL, 2021, 107 (01): : 32 - 38
  • [10] Update on real-world efficacy of anlotinib in non-small cell lung cancer
    Gao, Junzhen
    Xu, Yan
    Liu, Yonggang
    Liang, Li
    Yu, Yan
    Zhao, Dahai
    Jin, Jiahui
    Wang, Mengzhao
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345